Epistem Announces Tuberculosis Diagnostic Collaboration
Epistem plc announced the formation of a tuberculosis (TB) diagnostic collaboration with Xcelris Laboratories, one of India's Genomics research and Diagnostic testing companies. Epistem and Xcelris will be evaluating Epistem's Genedrive(TM) molecular device as part of India's RNTCP (Revised National Tuberculosis Control Programme) which started in 1997 and since 2006 has covered the whole of India to ensure the rapid diagnosis and treatment of TB sufferers.
The TB evaluation programme with Xcelris will continue through 2011, following which it is anticipated that it will be rolled out into a select number of remote locations prior to a full evaluation of market positioning.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.